Cargando…

Recommendations for the early diagnosis of COPD: the AIMAR view

Detalles Bibliográficos
Autor principal:	Celli, Bartolome R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344749/ https://www.ncbi.nlm.nih.gov/pubmed/25729573 http://dx.doi.org/10.1186/s40248-015-0005-4

Ejemplares similares

AIMAR survey on COPD phenotypes
por: Magnoni, Maria Sandra, et al.
Publicado: (2014)

The AIMAR recommendations for early diagnosis of chronic obstructive respiratory disease based on the WHO/GARD model*
por: Nardini, Stefano, et al.
Publicado: (2014)

AIMAR survey on complex forms of bronchial asthma and COPD, their management and perception of critical issues
por: Donner, Claudio F, et al.
Publicado: (2014)

COPD: time to improve its taxonomy?
por: Celli, Bartolomé R., et al.
Publicado: (2018)

Natural history of COPD: gaps and opportunities
por: Agustí, Alvar, et al.
Publicado: (2017)

Perception of symptoms and quality of life – comparison of patients’ and physicians’ views in the COPD MIRROR study
por: Celli, Bartolome, et al.
Publicado: (2017)

Selecting the Right Patient: The Achilles Heel of COPD Clinical Trials
por: Polverino, Francesca, et al.
Publicado: (2022)

Venous Admixture in COPD: Pathophysiology and Therapeutic Approaches
por: Cooper, Christopher B., et al.
Publicado: (2009)

From Laënnec’s Stethoscope to the Magic of Imaging, Big Data and Artificial Intelligence: A Timeline of Precision Medicine for Patients with Chronic Obstructive Pulmonary Disease
por: Celli, Bartolome
Publicado: (2023)

Spirometric variability in smokers: transitions in COPD diagnosis in a five-year longitudinal study
por: Sood, Akshay, et al.
Publicado: (2016)

Rhino-Bronchial Syndrome. The SIO-AIMAR (Italian Society of Otorhinolaryngology, Head Neck Surgery-Interdisciplinary Scientific Association for the Study of the Respiratory Diseases) survey
por: PASSALI, D., et al.
Publicado: (2011)

The clinical and integrated management of COPD. An official document of AIMAR (Interdisciplinary Association for Research in Lung Disease), AIPO (Italian Association of Hospital Pulmonologists), SIMER (Italian Society of Respiratory Medicine), SIMG (Italian Society of General Medicine)
por: Bettoncelli, Germano, et al.
Publicado: (2014)

Biomarkers in Early Diagnosis and Early Stage Lung Cancer: The Clinician’s Point of View
por: Gasparri, Roberto, et al.
Publicado: (2020)

The BODECOST Index (BCI): a composite index for assessing the impact of COPD in real life
por: Dal Negro, Roberto W., et al.
Publicado: (2016)

Recommendations for Diagnosis and Management of Osteoporosis in COPD Men
por: Mazokopakis, Elias E., et al.
Publicado: (2011)

Impact and prevention of severe exacerbations of COPD: a review of the evidence
por: Halpin, David MG, et al.
Publicado: (2017)

From pre-COPD to COPD: a Simple, Low cost and easy to IMplement (SLIM) risk calculator
por: Divo, Miguel J., et al.
Publicado: (2023)

Exacerbation frequency and course of COPD
por: Halpin, David MG, et al.
Publicado: (2012)

Enhancing the diagnosis and management of COPD in Primary care
por: Partridge, Martyn R
Publicado: (2014)

COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover Conference Series)
por: Polverino, Francesca, et al.
Publicado: (2018)

Corrigendum to “Recommendations for Diagnosis and Management of Osteoporosis in COPD Men”
por: Mazokopakis, Elias E., et al.
Publicado: (2017)

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal
por: Vanfleteren, Lowie, et al.
Publicado: (2018)

COPD heterogeneity: Gender differences in the multidimensional BODE index
por: de Torres, Juan P, et al.
Publicado: (2007)

Special Issue “Diagnosis, Treatment, and Management of COPD and Asthma”
por: Nishimura, Koichi
Publicado: (2023)

Adverse health consequences in COPD patients with rapid decline in FEV(1 )- evidence from the UPLIFT trial
por: Kesten, Steven, et al.
Publicado: (2011)

Is it Reasonable to Start Bronchodilator Treatment Before Confirming the Diagnosis of COPD?
por: Figueira-Gonçalves, Juan Marco, et al.
Publicado: (2023)

Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD
por: Cazzola, Mario, et al.
Publicado: (2023)

Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial
por: Hanania, Nicola A, et al.
Publicado: (2011)

Altered Gene Expression in Blood and Sputum in COPD Frequent Exacerbators in the ECLIPSE Cohort
por: Singh, Dave, et al.
Publicado: (2014)

Challenges in Tuberculosis Diagnosis and Management: Recommendations of the Expert Panel
por: Singh, Sarman, et al.
Publicado: (2015)

Sexually-dimorphic targeting of functionally-related genes in COPD
por: Glass, Kimberly, et al.
Publicado: (2014)

COPD Clinical Significance of Early Diagnosis
por: Leff, Richard D.
Publicado: (2005)

Women with COPD
por: McIvor, Emma R., et al.
Publicado: (2020)

From GOLD 0 to Pre-COPD
por: Han, MeiLan K., et al.
Publicado: (2021)

Diagnosis and Treatment of Hypovitaminosis D: Recommendations from India and Brazil
por: Alves, Cresio
Publicado: (2017)

Labs in the time of COVID: an early-career scientist's view
por: Chuang, Ling-shiang
Publicado: (2020)

Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT(®) Trial
por: Halpin, David M. G., et al.
Publicado: (2011)

Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT
por: Putcha, Nirupama, et al.
Publicado: (2022)

Metabolic and cardiorespiratory effects of decreasing lung hyperinflation with budesonide/formoterol in COPD: a randomized, double-crossover, placebo-controlled, multicenter trial
por: Divo, Miguel J., et al.
Publicado: (2020)

GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists
por: Agusti, Alvar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_52cd6n3d8uvhc340kjpfkgivsn